Ainos Inc (AIMD)vsMKS Instruments Inc (MKSI)
AIMD
Ainos Inc
$1.38
+0.73%
TECHNOLOGY · Cap: $10.56M
MKSI
MKS Instruments Inc
$231.50
-3.25%
TECHNOLOGY · Cap: $17.95B
Smart Verdict
WallStSmart Research — data-driven comparison
MKS Instruments Inc generates 31963135% more annual revenue ($4.35B vs $13,600). MKSI leads profitability with a 10.1% profit margin vs 0.0%. AIMD appears more attractively valued with a PEG of 0.93. MKSI earns a higher WallStSmart Score of 69/100 (B-).
AIMD
Avoid25
out of 100
Grade: F
MKSI
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AIMD.
Margin of Safety
-59.8%
Fair Value
$162.14
Current Price
$231.50
$69.36 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Earnings expanding 162.0% YoY
Strong operational efficiency at 20.6%
Revenue surging 28.3% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Elevated debt levels
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AIMD
The strongest argument for AIMD centers on PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.
Bull Case : MKSI
The strongest argument for MKSI centers on EPS Growth, Operating Margin, Revenue Growth. Revenue growth of 28.3% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bear Case : AIMD
The primary concerns for AIMD are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 4.21 is elevated, increasing financial risk.
Bear Case : MKSI
The primary concerns for MKSI are Debt/Equity, P/E Ratio, Altman Z-Score. A P/E of 42.3x leaves little room for execution misses.
Key Dynamics to Monitor
AIMD profiles as a value stock while MKSI is a growth play — different risk/reward profiles.
AIMD carries more volatility with a beta of 2.48 — expect wider price swings.
MKSI is growing revenue faster at 28.3% — sustainability is the question.
MKSI generates stronger free cash flow (189M), providing more financial flexibility.
Bottom Line
MKSI scores higher overall (69/100 vs 25/100) and 28.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ainos Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
MKS Instruments Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.
Visit Website →Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?